[New post] India Rejects Johnson & Johnson’s Attempt To Extend Monopoly On Lifesaving TB Drug

GGI Staff posted: " According to the Hindu, the Indian Patent Office has rejected Johnson & Johnson's attempt to extend a monopoly on a lifesaving TB drug. In a victory for patients fighting for wider access to crucial anti-tuberculosis drug Bedaquiline, the Indian P" GreatGameIndia India Rejects Johnson & Johnson's Attempt To Extend Monopoly On Lifesaving TB Drug GGI Staff Mar 26 According to the Hindu, the Indian Patent Office has rejected Johnson & Johnson's attempt to extend a monopoly on a lifesaving TB drug. Read more of this post Comment Unsubscribe to no longer receive posts from GreatGameIndia. Change your email settings at manage subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://greatgameindia.com/india-rejects-johnson-johnsons-attempt-to-extend-monopoly-on-lifesaving-tb-drug/

Get the Jetpack app to use Reader anywhere, anytime Follow your favorite sites, save posts to read later, and get real-time notifications for likes and comments. Learn how to build your website with our video tutorials on YouTube. Automattic, Inc. - 60 29th St. #343, San Francisco, CA 94110